The German biotech company Bionas GmbH, Rostock, has made a first study investigating primary human hepatocytes with in vitro test in the Bionas® 2500 analyzing system. The human primary hepatocytes were provided by Primacyt GmbH, located in Schwerin, Germany. Primacyt has a unique know-how for serum free long-term human primary hepatocytes cultures.
The Bionas® 2500 detects oxygen consumption, acidification and adhesion of cells on six sensor chips in parallel. All parameters are detected continuously and online during long-term measurements. Regeneration and recovery effects are monitored respectively. Primary human hepatocytes were cultured on collagen pre-coated chips in chemically defined Human Hepatocyte Maintenance Medium and, for comparison, in conventional two-dimensional cultures. The sensor chip based in vitro results were compared with standard assays for hepatocytes like albumin release and urea release. The effects of acetaminophen (AAP) were investigated. The cells were exposed to AAP (50 - 2815 mg/l) for 24 h. Cell respiration was obviously inhibited by AAP concentrations above 500 mg/l whereas cell adhesion was marginally reduced. In conventional two dimensional cultures AAP application reduced albumin release. Comparison of primary human and rat cells shows obviously different hepatotoxic effects of AAP.
It seems that the primary human hepatocytes are less effected as the rat cells or the cell line HepG2. In conclusion the primary human cells are closer at the in-vivo situation as rat cells or artificial cell lines. Distinct differences can be also found if primary rat hepatocytes or the HepG2 cell line are used in the Bionas® 2500 analyzing system.
The Bionas® 2500 analyzing system clearly predicts compound effects on metabolism of primary cells. The combination of these primary human hepatocytes with the Bionas® 2500 analyzing system opened new ways in drug discovery and toxicology.
Bionas was founded in 2001 as spin-off by members of the University of Rostock, Germany. In Rostock we are employing physicists, biochemists, chemists and hard- and software engineers. The Company has more then ten years of experience in the development of semiconductor sensor and its application on living cells. Main investors are Micronas Holding GmbH and GENIUS Venture Capital GmbH.
Bionas develops new tools for applications in the life sciences, drug discovery, cancer research and environment protection providing deeper insights into cell metabolism.
With this world's first ready-to-use sensor chip system, Bionas can reduce the need for animal testing and increase the safety of preclinical studies. So Bionas want to make a significant contribution to environmental protection and fight against cancer.
PRIMACYT Cell Culture Technology GmbH has its roots in HeparCell GmbH, originally founded by 4 private individuals in June 2004. In October 2005 HeparCell GmbH changed its corporate name to PRIMACYT Cell Culture Technology. With HEPAC2 the young biotech start up company has developed a long-term human hepatocyte culture system, that may be used as a biosensor for the analysis of drugs, food additives, and chemicals. HEPAC2 allows the repetitive application of drugs within one cell culture. Thereby, hepatocytes may not only be used for one experiment, but instead can be "recycled" and may be used after a recovery period for a second, a third or even a fourth round of experiments. Thus, the system is designed to reduce the number of animal experiments and to reduce the costs of preclinical studies.
Both companies are member of BioCon Valley, the life science initiative Mecklenburg-Vorpommern, Germany - a partner of ScanBalt fmba, Copenhagen.Contact:
Biologists unravel another mystery of what makes DNA go 'loopy'
16.03.2018 | Emory Health Sciences
Scientists map the portal to the cell's nucleus
16.03.2018 | Rockefeller University
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences